Replies to post #324326 on Avid Bioservices Inc (CDMO)

[biopharm]

Remember Dios, Stason, and gosh knows how many I forgot.

I believe Stason was just another way some sabotaged and delayed PS Targeting.....it is clear

"It reminds me of the Stason deal. Never to be heard of again. They are still in business. ..."
....
....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133022160

Has everyone looked into all Peregrine ties with ex Peregrine employee Janet Nuttall, relation Aidan Nuttall (ex Maxim, Chiltern, Abingdon Life Sciences that had dealings with Stason!...now working with Diana Wood and Janet Nuttall at KC Specialty Therapeutics in St Louis Missouri....

How many times has Peregrine been sabotaged?
....
...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133659467

If anyone connected back to these Janet Nuttall posts involved in any future deals this is 100% shifting profits and the deal should be null and void ...remember, Gerald Finken ...William (Bill) Schary with Abbvie ....Ramon Valencia ...David King all on this Nuttall bandwagon and all retail were left wondering.

https://www.linkedin.com/in/aidan-nuttall-4890666

https://www.linkedin.com/in/janet-nuttall-mph-3286a49

....
.....
Diana Wood, CEO of KCST added, "This acquisition brings together complementary strengths of Kangen and KCST and also enhances our strategic position and value with our partners in Japan." Diana Wood will take on the additional role of the President of Kangen, while Mr. Hirota will retain the chairperson position.

About Kangen
Kangen Pharmaceuticals Co., Ltd. was founded in 2005 by Mr. Hirota. Kangen, formerly known as Stason Pharma Japan, has been instrumental in establishing strategic relationships between KCST and its partners in Japan, now with several ongoing projects in various stages of the FDA review process. For more information, please visit: www.Kangenpharma.com
...
...

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137035573

Welcome to Kangen Pharma
Kangen Pharmaceuticals America is the US division of Kangen Pharmaceuticals, Co. Ltd. based in Tokyo, Japan.
Kangen America was formed through an acquisition of the assets of KC Specialty therapeutics, LLC (KCST)— previously a wholly-owned subsidiary of Stason Pharmaceuticals, Inc.
Kangen America focuses on working with companies outside of the US to develop products for the treatment of rare diseases and Orphan Indications within the US.

http://kangenpharma.com